Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 31 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 28 29 30 31 presentations: 1 to 25 of 775
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
Pre-analytical considerations and PCR based approaches
Frank Diehl
Sysmex Inostics, Inc., Mundelein, IL, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
NGS based approaches for ctDNA analysis: Laboratory
Davina Gale
Inivata Ltd., Cambridge, United Kingdom
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
NGS based approaches for ctDNA analysis: Bioinformatics
Maximilian Diehn
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
ctDNA analysis of structural changes
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Inhibiting immune checkpoints
Mary L. Disis
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Regulatory T cells
Dario A. Vignali
Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Regulatory myeloid cells
Dmitry I. Gabrilovich
The Wistar Institute, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Galectins and immune response in cancer
Gabriel A. Rabinovich
Instituto de BiologĂ­a y Medicina Experimental, CONICET, Ciudad de Buenos Aires, Argentina
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Interpreting the Biological and Clinical Significance of Mutations in Cancer
Overview
Barry S. Taylor
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Interpreting the Biological and Clinical Significance of Mutations in Cancer
Finding cancer genome variation in complex clinical specimens
Trevor J Pugh
Princess Margaret Cancer Centre, Toronto, ON, Canada
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Interpreting the Biological and Clinical Significance of Mutations in Cancer
Cancer genome sequencing: From initial surveys of the mutational landscape to building clinical applications
Obi L Griffith
Washington University School of Medicine, St Louis, MO, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Interpreting the Biological and Clinical Significance of Mutations in Cancer
Towards precision medicine: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Integration of Digital Technology into Epidemiologic Data Collection
Capturing diet in the digital age
Carol J. Boushey
University of Hawai'i, Honolulu, HI, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Integration of Digital Technology into Epidemiologic Data Collection
Novel approaches to integrating technology to assess physical activity in epidemiologic studies
Alpa V. Patel
American Cancer Society, Atlanta, GA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Integration of Digital Technology into Epidemiologic Data Collection
Measuring exposure to light using wearable devices
Mariana G Figueiro
Lighting Research Center, Rensselaer Polytechnic Institute, Troy, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Integration of Digital Technology into Epidemiologic Data Collection
Innovations in assessing patient outcomes
Heather S Jim
Moffitt Cancer Center, Tampa, FL, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Large Animal Models for Solid Tumor Oncology
Transitional, technical, and biological approaches and advances to address unmet clinical needs
Lawrence B. Schook
University of Illinois at Urbana-Champaign, Urbana, IL, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Large Animal Models for Solid Tumor Oncology
Unmet clinical needs in oncology: The value of large animal models
George J. Weiner
University of Iowa Holden Comp. Cancer Center, Iowa City, IA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Large Animal Models for Solid Tumor Oncology
The new pig on the block: Genome editing in cancer models
Angelika Schnieke
Technical University of Munich, Freising, Germany
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Large Animal Models for Solid Tumor Oncology
Organoid models and systems biology: From mouse to human
Michael M. Shen
Columbia University College of Physicians & Surgeons, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Introduction to measurable residual disease in the hematological malignancies
Christopher S. Hourigan
NHLBI, Bethesda, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Next-generation sequencing in the lymphoid malignancies
Aaron Logan
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Flow cytometry in the myeloid malignancies
Roland B Walter
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Regulatory aspects of MRD in clinical trials
Nicole J Gormley
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Bringing Longitudinal Research and Clinical Data Together to Accelerate Translation
Invited speaker
Andy Futreal
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 17, 2016 7:00 AM-8:00 AM
<< first | < prev page: of 31 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 28 29 30 31 presentations: 1 to 25 of 775